ENFN

Enfusion, Inc. (ENFN) 10Y Growth Potential Analysis (2026)

Invetso Score: 5.2/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Growth Runway

Revenue base remains small, leaving room for multi-year expansion if execution continues.

Gross margin is strong at 67.8%, supporting scalable growth economics.

Profitability

Operating margin is only 3.1% and net margin is 1.4%, indicating profitability is still thin.

Return on invested capital is 1.9%, showing limited current capital efficiency despite positive cash generation.

Financial Strength

Liquidity is solid with a current ratio of 3.4 and cash ratio of 2.0.

Balance sheet leverage is modest, with debt-to-equity at 0.28 and net debt to EBITDA negative at -5.6.

Cash Generation

Free cash flow yield is 3.0%, which is positive but not yet compelling for a premium growth multiple.

Capital intensity is low, with capex only 10.5% of operating cash flow.

Valuation

Valuation remains rich at 4.9x EV/sales and 32.9x price to free cash flow.

Earnings-based multiples are extremely elevated because trailing earnings are still minimal.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Enfusion, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →